We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

World's First Multiplex Biochip Identifies COVID, Flu, RSV, and Respiratory Pathogens in Less than 60 Seconds

By HospiMedica International staff writers
Posted on 01 Aug 2023
Print article
Image: The groundbreaking polymer-based biochip can directly detect whole viruses (Photo courtesy of Opteev)
Image: The groundbreaking polymer-based biochip can directly detect whole viruses (Photo courtesy of Opteev)

A revolutionary multiplex biochip for diagnosing respiratory infection has the potential to test multiple pathogens causing respiratory infections, such as SARS-CoV-2, RSV, and Influenza. The game-changing technology can accurately identify the specific virus or bacteria in less than a minute, paving the way for an ultra-rapid, portable, and accurate syndromic diagnostic device to provide healthcare providers with immediate results at their fingertips.

The tiny groundbreaking polymer-based biochip developed by Opteev Technologies (Baltimore, MD, USA) is capable of detecting whole viruses in real-time in processed as well as unprocessed samples like saliva or nasal swabs. It has shown an unparalleled accuracy rate of 99.49%, with an impressive detection limit in its performance evaluation. In a complex sample, the biosensor accurately identifies target viruses by using carefully selected virus-binding peptides, enhancing its specificity. The biochip employs artificial intelligence to fine-tune the detection frequency range, effectively reducing the effects of interfering noise signals, and ensuring the reliability and precision of virus detection.

In contrast to conventional respiratory panels that are expensive and require days for delivering results, Opteev's biochip offers a cost-effective solution for syndromic testing. It facilitates point-of-care processing of samples, providing simultaneous detection and specific identification of various pathogens. This game-changing technology eliminates guesswork, equipping healthcare providers with crucial information needed for effective treatment right at the point of care.

"With the development of our multiplex biochip, we are revolutionizing point-of-care diagnostics," said Dr. Mesfin Meshesha, Vice President of Virology & Diagnostics at Opteev Technologies. "The potential of this technology to transform patient care, streamline operations, and reduce costs is truly remarkable."

Related Links:
Opteev Technologies  

Gold Member
12-Channel ECG
Gold Member
Solid State Kv/Dose Multi-Sensor
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article


Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.